|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.75 USD | -0.56% |
|
-7.94% | -18.35% |
| 02-23 | Gilead to buy cancer therapy developer Arcellx for up to $7.8 billion | RE |
| 02-12 | Legend Biotech Shares Lower After Rothschild & Co Redburn Downgrade | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.56% | -7.94% | +6.29% | -36.90% | -18.35% | -48.85% | -61.65% | -27.58% | - | 3.3B | |
| -2.55% | -3.99% | -12.57% | -18.81% | -12.67% | +5.71% | +92.32% | +161.92% | +6,135.06% | 45.72B | |
| +0.47% | -5.67% | -4.80% | +2.27% | +2.00% | +54.34% | +11.05% | -18.17% | - | 39.82B | |
| -4.21% | -4.29% | -4.94% | -29.62% | -17.51% | +85.13% | +596.94% | +276.53% | +1,053.17% | 32.31B | |
| -1.78% | -6.30% | -3.40% | +5.92% | +7.09% | -11.17% | -22.04% | +5.98% | - | 26.05B | |
| +2.03% | -10.14% | -4.09% | +9.71% | +14.95% | +53.46% | -36.87% | -55.30% | - | 18.68B | |
| -1.03% | -3.24% | -10.69% | -12.65% | -12.43% | +7.28% | -30.72% | -6.65% | +116.46% | 17.17B | |
| +4.71% | -0.47% | +5.45% | -14.47% | -5.84% | +47.98% | +144.88% | +148.02% | - | 11.23B | |
| -2.86% | -5.44% | +7.87% | -18.41% | -14.58% | -23.58% | +870.13% | +163.49% | +126.37% | 11.93B | |
| -0.98% | -6.78% | -2.57% | -6.94% | -5.82% | +6.80% | +140.70% | +84.86% | +904.38% | 10.83B | |
| +5.30% | +0.21% | -8.27% | -12.92% | -1.02% | +54.29% | - | - | - | 10.38B | |
| -0.44% | -6.18% | +58.87% | +291.27% | +352.53% | +192.81% | +352.53% | - | - | 9.25B | |
| +6.86% | -17.62% | -3.44% | +8.93% | -24.50% | - | - | - | - | 8.93B | |
| +1.04% | -1.46% | -5.20% | -23.90% | -24.56% | +26.51% | +61.34% | +277.83% | - | 9.97B | |
| -2.30% | +0.33% | -1.61% | +3.52% | -4.20% | +266.57% | +96.60% | -7.83% | +1,368.82% | 9.12B | |
| -3.13% | -2.92% | +8.05% | +25.32% | +26.25% | -21.17% | +36.93% | +145.16% | - | 8.65B | |
| +2.84% | -4.83% | -6.13% | +34.31% | +46.60% | +22.14% | +53.23% | +526.72% | +366.22% | 7.86B | |
| -2.47% | -3.66% | -0.76% | -8.64% | -0.46% | +39.09% | +234.32% | - | - | 8.07B | |
| -0.13% | -0.70% | +3.24% | -5.30% | -2.12% | +41.73% | +48.25% | +216.01% | +891.87% | 7.67B | |
| +15.83% | -7.33% | -4.84% | -7.08% | -11.45% | +321.67% | +751.44% | +739.34% | - | 5.78B | |
| Average | +0.79% | -6.34% | +0.82% | +9.28% | +14.69% | +58.99% | +185.52% | +164.40% | +1,370.29% | 15.14B | |
| Weighted average by Cap. | -0.31% | -5.93% | -2.48% | +1.93% | +6.87% | +46.65% | +167.88% | +124.35% | +2,454.64% |
- Stock Market
- Equities
- LEGN Stock
- Sector Legend Biotech Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition